Journal of Jilin University(Medicine Edition) ›› 2024, Vol. 50 ›› Issue (6): 1677-1682.doi: 10.13481/j.1671-587X.20240621
• Research in clinical medicine • Previous Articles Next Articles
Suzhen YUAN,Yan JIN,Wenwen WANG(
)
Received:2023-12-13
Online:2024-11-28
Published:2024-12-10
Contact:
Wenwen WANG
E-mail:wenwenwang@hust.edu.cn
CLC Number:
Suzhen YUAN,Yan JIN,Wenwen WANG. Analysis on clinical characteristics of patients with ovarian clear cell carcinoma and ovarian endometriosis[J].Journal of Jilin University(Medicine Edition), 2024, 50(6): 1677-1682.
Tab.1
Clinical data of patients in two groups"
| Variable | OCCC | OMA | χ2/t/Z | P |
|---|---|---|---|---|
| Age(year) | 86.040 | <0.01 | ||
| <30 | 2(2.50) | 27(33.75) | ||
| 30-40 | 3(3.75) | 36(45.00) | ||
| ≥40 | 75(93.75) | 17(21.25) | ||
| BMI(kg·m-2)(x±s) | 22.19±2.55 | 21.39±2.86 | -1.251 | 0.215 |
| CA125(U·mL-1)[M(P25,P75)] | 165.95(55.65,513.15) | 34.85(15.72,77.28) | -6.044 | <0.01 |
| Abdominal pain(n/%) | ||||
| Yes | 30(37.50) | 20(25.00) | 2.909 | 0.088 |
| No | 50(62.50) | 60(75.00) | ||
| Vaginal bleeding(n/%) | 0.427 | 0.514 | ||
| Yes | 6(7.50) | 4(5.00) | ||
| No | 74(92.50) | 76(95.00) | ||
| Pelvic effusion(n/%) | 16.410 | <0.01 | ||
| Yes | 38(47.50) | 14(17.50) | ||
| No | 42(52.50) | 66(82.50) | ||
| Other symptoms(n/%) | 10.417 | <0.01 | ||
| Yes | 58(72.50) | 38(47.50) | ||
| No | 22(27.50) | 42(52.50) | ||
| Complex ovarian cyst(n/%) | 27.435 | <0.01 | ||
| Yes | 53(66.25) | 20(25.00) | ||
| No | 27(33.75) | 60(75.00) | ||
| Ovarian cyst size(cm)(x±s) | 12.27±5.36 | 6.04±2.59 | -9.366 | <0.01 |
Tab.2
Risk factors of OCCC analyzed by Logistic regression analysis"
| Variable | B | SE | OR(95%CI) | P |
|---|---|---|---|---|
| Age(year) | ||||
| <30 | 1.000 | |||
| 30-40 | -2.588 | 1.942 | 0.075(0.002—3.381) | 0.183 |
| ≥40 | 4.041 | 1.182 | 56.856(5.611—576.082) | 0.001 |
| Complex ovarian cyst | ||||
| Yes | 1.488 | 0.746 | 4.427(1.025—19.114) | 0.046 |
| No | 1.000 | |||
| Pelvic effusion | ||||
| Yes | 2.170 | 0.876 | 8.760(1.574—48.760) | 0.013 |
| No | ||||
| Other symptoms | ||||
| Yes | 1.311 | 0.740 | 3.709(0.871—15.806) | 0.076 |
| No | 1.000 | |||
| Ovarian cyst size(cm) | 0.578 | 0.150 | 1.782(1.329—2.390) | |
| CA125 fold | -0.008 | 0.018 | 0.992(0.958—1.027) | 0.639 |
| 1 | TORRE L A, TRABERT B, DESANTIS C E, et al. Ovarian cancer statistics, 2018[J]. CA Cancer J Clin, 2018, 68(4): 284-296. |
| 2 | TAN D S, KAYE S. Ovarian clear cell adenocarcinoma: a continuing enigma[J]. J Clin Pathol, 2007, 60(4): 355-360. |
| 3 | SILVERBERG S G. Ultrastructure and histogenesis of clear cell carcinoma of the ovary[J]. Am J Obstet Gynecol, 1973, 115(3): 394-400. |
| 4 | 中国医师协会妇产科医师分会妇科肿瘤学组. 卵巢透明细胞癌临床诊治中国专家共识(2022年版)[J]. 中国实用妇科与产科杂志, 2022, 38(5): 515-523. |
| 5 | MACHIDA H, MATSUO K, YAMAGAMI W, et al. Trends and characteristics of epithelial ovarian cancer in Japan between 2002 and 2015: a JSGO-JSOG joint study[J]. Gynecol Oncol, 2019, 153(3): 589-596. |
| 6 | GAN M F, TAI Z X, YU Y J, et al. Next-generation sequencing shows the genomic features of ovarian clear cell cancer and compares the genetic architectures of high-grade serous ovarian cancer and clear cell carcinoma in ovarian and endometrial tissues[J]. Peer J, 2023, 11: e14653. |
| 7 | IIDA Y, OKAMOTO A, HOLLIS R L, et al. Clear cell carcinoma of the ovary: a clinical and molecular perspective[J]. Int J Gynecol Cancer, 2021, 31(4): 605-616. |
| 8 | CHAN J K, TEOH D, HU J M, et al. Do clear cell ovarian carcinomas have poorer prognosis compared to other epithelial cell types? A study of 1411 clear cell ovarian cancers[J]. Gynecol Oncol, 2008, 109(3): 370-376. |
| 9 | XIE Y K, KONG W M, LUO D, et al. Ovarian clear cell carcinoma: genomic characterization, pathogenesis and targeted therapy[J]. Anticancer Res, 2023, 43(8): 3401-3410. |
| 10 | IRODI A, RYE T, HERBERT K, et al. Patterns of clinicopathological features and outcome in epithelial ovarian cancer patients: 35 years of prospectively collected data[J]. BJOG, 2020, 127(11): 1409-1420. |
| 11 | OLIVER K E, BRADY W E, BIRRER M, et al. An evaluation of progression free survival and overall survival of ovarian cancer patients with clear cell carcinoma versus serous carcinoma treated with platinum therapy: an NRG Oncology/Gynecologic Oncology Group experience[J]. Gynecol Oncol, 2017, 147(2): 243-249. |
| 12 | LIU H, XU Y B, JI J L, et al. Prognosis of ovarian clear cell cancer compared with other epithelial cancer types: a population-based analysis[J]. Oncol Lett, 2020, 19(3): 1947-1957. |
| 13 | 丁璐璟, 龚亚红, 李顺珍, 等. 彩色多普勒超声检测在卵巢良恶性肿瘤鉴别诊断中的价值[J]. 中国超声医学杂志, 2022, 38(4): 418-421. |
| 14 | KOBAYASHI H. Clinicopathological characteristics, molecular features and novel diagnostic strategies for the detection of malignant transformation of endometriosis (Review)[J]. Exp Ther Med, 2023, 25(6): 279. |
| 15 | FUJIWARA K, SHINTANI D, NISHIKAWA T. Clear-cell carcinoma of the ovary[J]. Ann Oncol, 2016, 27(): i50-i52. |
| 16 | ZHU C C, ZHU J, QIAN L L, et al. Clinical characteristics and prognosis of ovarian clear cell carcinoma: a 10-year retrospective study[J]. BMC Cancer, 2021, 21(1): 322. |
| 17 | WANG S, QIU L, LANG J H, et al. Clinical analysis of ovarian epithelial carcinoma with coexisting pelvic endometriosis[J]. Am J Obstet Gynecol, 2013, 208(5): 413.e1-413.e5. |
| 18 | BENNETT J A, MORALES-OYARVIDE V, CAMPBELL S, et al. Mismatch repair protein expression in clear cell carcinoma of the ovary: incidence and morphologic associations in 109 cases[J]. Am J Surg Pathol, 2016, 40(5): 656-663. |
| 19 | HÖHN A K, BRAMBS C E, HILLER G G R, et al. 2020 WHO classification of female genital tumors[J]. Geburtshilfe Frauenheilkd, 2021, 81(10): 1145-1153. |
| 20 | KADAN Y, FIASCONE S, MCCOURT C, et al. Predictive factors for the presence of malignant transformation of pelvic endometriosis[J]. Eur J Obstet Gynecol Reprod Biol, 2015, 185: 23-27. |
| 21 | HUANG K J, LI Y X, WU C J, et al. Sonographic features differentiating early-stage ovarian clear cell carcinoma from endometrioma with atypical features[J]. J Ovarian Res, 2022, 15(1): 84. |
| 22 | KOBAYASHI H, SUGIMOTO H, ONISHI S, et al. Novel biomarker candidates for the diagnosis of ovarian clear cell carcinoma[J]. Oncol Lett, 2015, 10(2): 612-618. |
| 23 | MURAKAMI K, KOTANI Y, SHIRO R, et al. Endometriosis-associated ovarian cancer occurs early during follow-up of endometrial cysts[J]. Int J Clin Oncol, 2020, 25(1): 51-58. |
| 24 | KRÁLÍČKOVÁ M, LAGANÀ A S, GHEZZI F, et al. Endometriosis and risk of ovarian cancer: what do we know?[J]. Arch Gynecol Obstet, 2020, 301(1): 1-10. |
| 25 | LEENEN S, HERMENS M, DE VOS VAN STEENWIJK P J, et al. Immunologic factors involved in the malignant transformation of endometriosis to endometriosis-associated ovarian carcinoma[J]. Cancer Immunol Immunother, 2021, 70(7): 1821-1829. |
| 26 | ROBINSON K A, MENIAS C O, CHEN L W, et al. Understanding malignant transformation of endometriosis: imaging features with pathologic correlation[J]. Abdom Radiol, 2020, 45(6): 1762-1775. |
| 27 | CHIANG A J, CHANG C, HUANG C H, et al. Risk factors in progression from endometriosis to ovarian cancer: a cohort study based on medical insurance data[J]. J Gynecol Oncol, 2018, 29(3): e28. |
| [1] | Jing YU,Yinzhuo HUANG,Zhongwei ZHOU,Yuxin XIE,Qian MAO. Analysis on influencing factors in type 2 diabetes mellitus patients complicated with lower limb atherosclerosis and construction of nomogram model [J]. Journal of Jilin University(Medicine Edition), 2026, 52(3): 806-812. |
| [2] | Yuyang LI,Xiang LI,He SHI,Yiwen QIN,Zhaorong XIAO,Sihao CHEN,Cong ZHAO,Weiwei LIU. Analyses of etiology characteristics and risk factors for postoperative infection in patients underwent oral and maxillofacial surgery [J]. Journal of Jilin University(Medicine Edition), 2026, 52(2): 507-512. |
| [3] | Chuwen WU,Mengling PENG,Yu FU,Shanshan ZHOU. Comparison of clinical characteristics and prognostic influence factors between patients with or without hypertrophic cardiomyopathy complicated by microvascular dysfunction [J]. Journal of Jilin University(Medicine Edition), 2025, 51(6): 1630-1637. |
| [4] | Xiao LI,Li WANG,Wen WU,Rui WANG,Aiying ZHANG,Shuo ZHANG,Rujia JIANG,Yaning MENG. Clinical outcomes and risk factors analysis on infection in patients with bullous pemphigoid [J]. Journal of Jilin University(Medicine Edition), 2025, 51(5): 1312-1317. |
| [5] | Shengmin ZHANG,Xinyu MENG,Yingzhen XU,Jingwen SUN,Zhikang MAO,Shuzhe ZHOU,Tianhang ZHOU,Yilin YUAN,Chenmei XIE,Xinrui ZHAO,Yantao MA,Hong MA,Xin YU,Lili GUAN. Clinical characteristics analysis on clinical high-risk patients with bipolar disorder [J]. Journal of Jilin University(Medicine Edition), 2025, 51(4): 1061-1071. |
| [6] | Jiahui FENG,Renjie LIU,Xuan CHEN. Analysis on risk factors of development of acute hydrocephalus in patients with aneurysmal subarachnoid hemorrhage [J]. Journal of Jilin University(Medicine Edition), 2025, 51(3): 763-769. |
| [7] | Honghong LI,Na YU,Minghao SHI,Ying SUN,Yao LI,Zhongjun SHEN,Xiaoyi LIU,Liyan ZHAO. Predictive value of new thrombotic risk assessment model for venous thromboembolism in patients with malignant tumors [J]. Journal of Jilin University(Medicine Edition), 2024, 50(5): 1390-1399. |
| [8] | Jiayuan YU,Di ZHAO,Xin JIANG,Jing XU,Lili JIANG,Hongyu JIANG. Association analysis on peripheral blood lymphocyte subsets and occurrence of carotid atherosclerosis [J]. Journal of Jilin University(Medicine Edition), 2024, 50(5): 1400-1405. |
| [9] | Peng QI,Xianying MENG,Meihua PIAO,Qiang ZHANG. Network Meta-analysis on risk factors of recurrence of papillary thyroid microcarcinoma [J]. Journal of Jilin University(Medicine Edition), 2023, 49(6): 1504-1512. |
| [10] | Xiunan FENG,Lu CHEN,Yu LONG,Zhenyu JIANG,Ling ZHAO. Analysis on clinical characteristics and risk factors of patients with Sjogren’s syndrome complicated with interstitial lung disease [J]. Journal of Jilin University(Medicine Edition), 2023, 49(6): 1513-1518. |
| [11] | Xue DONG, Jinfeng ZANG, Caifeng XU, Hebing LIU, Zhaohua CHENG. Construction and validation of risk prediction model of enteral nutrition feeding intolerance of patients with severe acute pancreatitis [J]. Journal of Jilin University(Medicine Edition), 2023, 49(6): 1586-1592. |
| [12] | Tong SHEN,Yang WANG,Wei JIN,Zhihui LIN,Li YAN. Risk factors analysis and risk model construction of cognitive frailty in elderly patients with chronic diseases [J]. Journal of Jilin University(Medicine Edition), 2023, 49(5): 1304-1309. |
| [13] | Mingfei JU,Chao LIU,Zhigang MA,Juan ZHAO,Tu WANG,Zhihao WANG. Predictive value of residual cholesterol in occurrence of patients with acute coronary syndrome [J]. Journal of Jilin University(Medicine Edition), 2023, 49(3): 765-769. |
| [14] | Lianyuan WANG,Yi YANG,Huiwen CONG,Haohua WANG,Qihan BAO,Chengsheng LI,Liwen ZHOU,Zichen DING,Yanli LI,Fuyan SHI,Suzhen WANG. Bayesian quantile regression joint model analysis on risk factors of Alzheimer’s disease in people with different MMSE scores [J]. Journal of Jilin University(Medicine Edition), 2023, 49(2): 395-401. |
| [15] | Shan GAO,Yutong WANG,Minqiu LU,Lei SHI,Bin CHU,Yuehua DING,Mengzhen WANG,Li BAO. Analysis on causes for early death and its risk factors of patients with multiple myeloma in era of novel drugs [J]. Journal of Jilin University(Medicine Edition), 2022, 48(3): 783-789. |
|